Alignment Healthcare (ALHC) Cash & Equivalents (2020 - 2026)

Alignment Healthcare (ALHC) has 7 years of Cash & Equivalents data on file, last reported at $705.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 58.14% year-over-year to $705.6 million; the trailing twelve-month figure through Mar 2026 stood at $705.6 million (up 58.14% YoY), and the FY2025 full-year result was $575.8 million, up 33.03% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $705.6 million, up from $575.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $705.6 million in Q1 2026 and bottomed at $202.9 million in Q4 2023.
• The 5-year median for Cash & Equivalents is $432.9 million (2024), against an average of $436.5 million.
• The widest annual swing landed in 2023, when Cash & Equivalents slumped 50.46%; it then soared 113.33% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $409.5 million in 2022, then plunged by 50.46% to $202.9 million in 2023, then jumped by 113.33% to $432.9 million in 2024, then soared by 33.03% to $575.8 million in 2025, then climbed by 22.54% to $705.6 million in 2026.
• The last three Cash & Equivalents figures came in at $705.6 million (Q1 2026), $575.8 million (Q4 2025), and $618.1 million (Q3 2025), per Business Quant data.

Peer Comparison